DHEA-S is an adrenal-derived precursor that helps determine women's testosterone levels.

Dehydroepiandrosterone sulfate (DHEA-S) is a fundamental prohormone in female physiology, serving as the most abundant circulating steroid and the primary reservoir for the synthesis of active sex steroids. In women, this precursor system is particularly critical, as approximately half of all androgens are synthesized from DHEA and DHEA-S in peripheral tissues through localized metabolic processes.

Clinical and effectiveness evidence

In female physiology, DHEA-S levels are a strong predictor of overall androgen status. Clinical studies demonstrate that lower circulating DHEA-S concentrations correlate with reduced bioavailability of testosterone and its metabolites.

• Interventional impact: Supplementation with DHEA in women has been shown to significantly elevate serum levels of total testosterone, free testosterone, and androstenedione.
• Androgen pool: Because adrenal-derived DHEA-S provides the raw substrate for roughly 50% of the total androgen pool in women, a decline or deficiency in this precursor directly limits the capacity for peripheral testosterone synthesis.

Mechanistic explanations

The conversion of DHEA-S into testosterone involves a series of well-defined enzymatic steps across various tissues, including the skin, adipose tissue, and muscle.

• Adrenal dominance: The adrenal glands (specifically the zona reticularis) are responsible for 90–95% of circulating DHEA-S. This is driven by high expression of the enzyme SULT2A1, which sulfates DHEA for stable transport in the blood.
• Intracrinology: Peripheral tissues utilize the enzyme steroid sulfatase (STS) to convert DHEA-S back into free DHEA. Once in this form, 3β-hydroxysteroid dehydrogenase (3β-HSD) and 17β-hydroxysteroid dehydrogenase (17β-HSD) convert DHEA into androstenedione and then into active testosterone.
• Localized synthesis: This system allows cells to produce androgens according to local physiological demand, independent of direct gonadal production.

Bottom line

The claim is robustly supported; DHEA-S is almost exclusively an adrenal product (90–95%) that serves as the essential substrate for peripheral testosterone synthesis. Consequently, low DHEA-S levels directly reduce the precursor pool available for maintaining healthy testosterone levels in women.